NASDAQ
Cidara Therapeutics, Inc. (CDTX) has a fcf yield of -103.51% as of Friday, May 29, 2026. This represents a 117.01% decrease compared to its 12-month average of -47.70%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.